{"id":42126,"date":"2026-03-17T17:29:18","date_gmt":"2026-03-17T17:29:18","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/42126\/"},"modified":"2026-03-17T17:29:18","modified_gmt":"2026-03-17T17:29:18","slug":"novo-nordisk-nvo-partners-with-hims-hers-heres-what-you-need-to-know-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/42126\/","title":{"rendered":"Novo Nordisk (NVO) Partners With Hims & Hers, Here\u2019s What You Need to Know"},"content":{"rendered":"\n

Novo Nordisk A\/S (NYSE:NVO<\/a>) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts<\/a>. On March 9, Novo Nordisk A\/S (NYSE:NVO) announced its partnership with Hims & Hers. The deal entails access to Novo\u2019s GLP-1 drugs, Ozempic and Wegovy, at Hims & Hers\u2019 platform.<\/p>\n

\u200bManagement noted that as part of this deal, Hims & Hers will sell FDA-approved Ozempic injections and Wegovy in tablet form and injections at \u201caffordable self-pay prices\u201d matching other telehealth sites. Moreover, Hims and Hers will also stop selling and advertising compounded GLP-1s; as a result, existing patients will have the opportunity to use FDA-approved treatments.<\/p>\n

\"\" <\/p>\n

\u200bIn addition, Novo Nordisk is also dropping its patent lawsuit against Hims & Hers, but can refile later. NVO\u2019s CEO Mike Doustdar noted this as a \u201cwin for patients\u201d by prioritizing safe, proven FDA-approved meds over riskier compounds. It counters competition from telehealth firms undercutting prices with unapproved knockoffs, which have surged amid GLP-1 demand.<\/p>\n

\u200bNovo Nordisk A\/S (NYSE:NVO) is a global healthcare company that develops, manufactures, and markets medicines for serious chronic diseases. It is a leader in diabetes care (including insulin and Ozempic), obesity management (Wegovy), haemophilia care, and rare endocrine disorders.<\/p>\n

While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock<\/a>.<\/p>\n

READ NEXT: 33 Stocks That Should Double in 3 Years<\/a> and 15 Stocks That Will Make You Rich in 10 Years.<\/a><\/p>\n

Disclosure: None. Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk A\/S (NYSE:NVO) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts.…\n","protected":false},"author":2,"featured_media":8834,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[621,1440,272],"class_list":["post-42126","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-hims","tag-hims-hers","tag-novo-nordisk"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116245703178063400","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/42126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=42126"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/42126\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/8834"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=42126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=42126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=42126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}